2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Molecular and biochemical basis <strong>of</strong> disease<br />
P05.148<br />
Exon resequencing, mutation detection, and copy number<br />
analysis in syndromic oesophageal atresia<br />
M. Storer1 , E. Howard1 , V. Martin2 , G. LeFebvre1 , A. C<strong>of</strong>fey1 , C. J. Shaw-<br />
Smith1 ;<br />
1 2 Wellcome Trust Sanger Institute, Cambridge, United Kingdom, Institute <strong>of</strong><br />
Child Health, London, United Kingdom.<br />
Oesophageal atresia and/or tracheo-oesophageal fistula are common<br />
malformations occurring in approximately 1 in 3500 births . In around<br />
half <strong>of</strong> cases (syndromic oesophageal atresia, overlapping with the<br />
VACTERL association), there are associated anomalies, cardiac malformations<br />
being the most common . Recently, three separate genes<br />
with a role in syndromic oesophageal atresia have been identified:<br />
those for Feingold syndrome (N-MYC), anophthalmia-oesophagealgenital<br />
(AEG) syndrome (SOX2), and CHARGE syndrome (CHD7) . It<br />
is likely that other genes play a role in foregut development, and dosage<br />
sensitive chromosomal loci presumably harbouring these as yet<br />
unidentified genes have recently been highlighted (refs 1 and 2).<br />
We are collecting DNA samples from patients with syndromic forms <strong>of</strong><br />
oesophageal atresia and the VACTERL association . We are analyzing<br />
these samples by exon resequencing in the CHD7, N-MYC, SALL1<br />
and SOX2 genes (additional genes, including FANCB and FANCC are<br />
currently being added to the panel); and by high resolution array-based<br />
comparative genomic hybridization (arrayCGH) . To date, we have analyzed<br />
50 samples . No de novo copy number changes have as yet been<br />
identified. A de novo frame shift mutation has been detected in CHD7<br />
in a single patient with some features <strong>of</strong> CHARGE syndrome .<br />
By adopting this comprehensive approach to the analysis <strong>of</strong> a single<br />
malformation, we hope to identify other genes involved in human foregut<br />
development and to continue to provide a research-based service<br />
to the Clinical <strong>Genetics</strong> community for this patient group .<br />
1 . Shaw-Smith C. J Med Genet . 2006: 43(7):545-54 .<br />
2 . Felix JF, et al Eur J Med Genet . 2007: 50(3):163-75<br />
P05.149<br />
mutational spectrum <strong>of</strong> the Oral-facial-digital type i syndrome: a<br />
study on a large collection <strong>of</strong> patients<br />
B. Franco1,2 , C. Prattichizzo1 , M. Macca1,2 , V. Novelli1 , G. Giorgio1 , A. Barra1 ,<br />
OFDI collaborative group;<br />
1 2 Telethon Institute <strong>of</strong> <strong>Genetics</strong> and Medicine-TIGEM, Naples, Italy, Department<br />
<strong>of</strong> Pediatrics, University Federico II, Naples, Italy.<br />
Oral-facial-digital type I (OFDI; MIM 311200) syndrome is a male-lethal<br />
X-linked dominant developmental disorder belonging to the heterogeneous<br />
group <strong>of</strong> Oral-facial-digital syndrome (OFDS) . OFDI is characterized<br />
by malformations <strong>of</strong> the face, oral cavity and digits . CNS abnormalities<br />
and cystic kidney disease can also be part <strong>of</strong> this condition .<br />
This rare genetic disorder is due to mutations in the OFD1 gene that<br />
encodes a centrosome/basal body protein necessary for primary cilium<br />
assembly and for left-right axis determination, thus ascribing OFDI<br />
to the growing number <strong>of</strong> disorders associated to ciliary dysfunction .<br />
We now report a mutation analysis study in a cohort <strong>of</strong> 100 unrelated<br />
affected individuals collected worldwide . Putative disease-causing mutations<br />
were identified in 81 patients (81%). We describe 67 different<br />
mutations, 64 <strong>of</strong> which represent novel mutations, including 36 frameshift,<br />
9 missense, 11 splice-site and 11 nonsense mutations . Most <strong>of</strong><br />
them concentrate in exons 3, 8, 9, 12, 13 and 16, suggesting that these<br />
exons may represent mutational hotspots . Phenotypic characterization<br />
<strong>of</strong> the patients provided a better definition <strong>of</strong> the clinical features <strong>of</strong><br />
OFD type I syndrome . Our results indicate that renal cystic disease is<br />
present in 60% <strong>of</strong> cases with >18 years <strong>of</strong> age . Genotype-phenotype<br />
correlation did not reveal significant associations apart for the higharched/cleft<br />
palate most frequently associated to missense and splicesite<br />
mutations . Our results contribute to further expand our knowledge<br />
on the molecular basis <strong>of</strong> OFD type I syndrome .<br />
P05.150<br />
the Opitz syndrome gene product miD1 assembles a<br />
microtubule-associated ribonucleoprotein complex<br />
B. Aranda Orgilles 1 , A. Trockenbacher 2 , J. Winter 3 , J. Aigner 1 , A. Köhler 2 , E.<br />
Jastrzebska 1 , J. Stahl 4 , R. Schneider 2,3 , S. Schweiger 1,5 ;<br />
1 Max Planck institute for molecular genetics, berlin, Germany, 2 Institute <strong>of</strong><br />
Biochemistry, Innsbruck, Austria, 3 Max Planck Institute for molecular genetics,<br />
Berlin, Germany, 4 Max-Delbrueck Center <strong>of</strong> Molecular Medicine, berlin,<br />
Germany, 5 Medical School, Division <strong>of</strong> Pathology and Neuroscience, Dundee,<br />
United Kingdom.<br />
Opitz BBB/G syndrome (OS) is a heterogenous malformation syndrome<br />
mainly characterised by hypertelorism and hypospadias . In<br />
addition, patients may present with several other defects <strong>of</strong> the ventral<br />
midline such as cleft lip and palate and congenital heart defects .<br />
The syndrome-causing gene encodes the X-linked E3 ubiquitin ligase<br />
MID1 that mediates ubiquitin-specific modification and degradation <strong>of</strong><br />
the catalytic subunit <strong>of</strong> the translation regulator protein phosphatase<br />
2A (PP2A) . Here, we show that the MID1 protein also associates with<br />
elongation factor 1α (EF-1α) and several other proteins involved in<br />
mRNA transport and translation, including RACK1, Annexin A2, Nucleophosmin<br />
and proteins <strong>of</strong> the small ribosomal subunits . Mutant<br />
MID1 proteins as found in OS patients lose the ability to interact with<br />
EF-1α. The composition <strong>of</strong> the MID1 protein complex was determined<br />
by several independent methods: (1) yeast two-hybrid screening, (2)<br />
immun<strong>of</strong>luorescence, (3) a biochemical approach involving affinity<br />
purification <strong>of</strong> the complex, (4) co-fractionation in a microtubule assembly<br />
assay and (5) immunoprecipitation . Moreover, we show that<br />
the cytoskeleton-bound MID1/translation factor complex specifically<br />
associates with G- and U-rich RNAs and incorporates MID1 mRNA,<br />
thus forming a microtubule-associated ribonucleoprotein (RNP) complex<br />
. Our data suggest a novel function <strong>of</strong> the OS gene product in<br />
directing translational control to the cytoskeleton . The dysfunction <strong>of</strong><br />
this mechanism would lead to malfunction <strong>of</strong> microtubule-associated<br />
protein translation and to the development <strong>of</strong> OS .<br />
P05.151<br />
Large genomic rearrangements <strong>of</strong> the OFD gene account for<br />
20 % <strong>of</strong> patients with Oral-Facial-Digital type 1 syndrome and<br />
negative DNA sequencing analysis<br />
C. Thauvin-Robinet 1,2 , B. Franco 3 , P. Saugier-Veber 4 , N. Gigot 5 , B. Aral 5 , A.<br />
Donzel 5 , L. Van Maldergem 6 , E. Bieth 7 , V. Layet 8 , M. Mathieu 9 , A. Teebi 10 , T.<br />
Morisawa 11 , M. Matsuo 11 , L. Burglen 12 , V. Cormier-Daire 13 , A. Masurel-Paulet 1,2 ,<br />
E. Gautier 14 , F. Huet 15 , J. Teyssier 5 , M. Tosi 4 , T. Frebourg 4 , L. Faivre 1,2 ;<br />
1 centre de génétique, Dijon, France, 2 Centre de Références Maladies Rares<br />
- Anomalies du Développement Embryonnaire et syndromes malformatifs- de<br />
la Région Grand Est, CHU, Dijon, France, 3 Laboratorio di Ricerca, Telethon<br />
Institute <strong>of</strong> <strong>Genetics</strong> and Medicine (TIGEM), Napoli, Italy, 4 Laboratoire de génétique<br />
moléculaire, Service de génétique, Faculté de médecine et de pharmacie,<br />
Rouen, France, 5 Laboratoire de Génétique Moléculaire, Hôpital du Bocage,<br />
CHU, Dijon, France, 6 Institut de Pathologie et de Génétique, Loverval, Belgium,<br />
7 Laboratoire de Génétique, CHU Purpan, Toulouse, France, 8 Unité de Cytogénétique<br />
et Génétique médicale, CH, Le Havre, France, 9 Centre de référence<br />
- Anomalies du développement et syndromes malformatifs – de la région Nord,<br />
Département de pédiatrie - Unité de génétique clinique, CHU Hôpital Nord,<br />
Amiens, France, 10 Division <strong>of</strong> clinical and Metabolic <strong>Genetics</strong>, The Hospital <strong>of</strong><br />
Sick Children, Toronto, ON, Canada, 11 Department <strong>of</strong> Pediatrics, Kobe University<br />
Graduate School <strong>of</strong> Medicine, Kobe, Japan, 12 Centre de référence des<br />
malformations et maladies congénitales du cervelet, Service de génétique et<br />
d’embryologie médicales, CHU Hôpital d’Enfants Armand-Trousseau, APHP,<br />
Paris, France, 13 Département de Génétique, Hôpital Necker-Enfants Malades,<br />
APHP, Paris, France, 14 CIC-EC, Hôpital Le Bocage, CHU, Dijon, France, 15 Service<br />
de Pédiatrie 1, Hôpital d’Enfants, CHU, Dijon, France.<br />
Among the oral-facial-digital syndromes, the oral-facial-digital type<br />
1 syndrome (OFD 1) is characterised by X-linked dominant mode <strong>of</strong><br />
inheritance . Clinical features include facial dysmorphism with oral,<br />
tooth and distal abnormalities, polycystic kidney disease and central<br />
nervous system malformations . A high clinical overlap exists between<br />
the different types <strong>of</strong> OFD syndrome . OFD1 DNA sequencing analysis<br />
remains negative in 30 to 50% <strong>of</strong> cases . We hypothesized that large<br />
genomic rearrangements could account for the majority <strong>of</strong> these unexplained<br />
cases . A series <strong>of</strong> 25 index cases (29 patients) with OFD1 phenotype<br />
and normal OFD1 DNA sequencing analysis were screened for<br />
OFD1 rearrangements by QMPSF and relative quantitative real-time<br />
PCR analyses . Five large deletions (exons 1-8, exons 1-14, exons 10-<br />
11, exon 17 and exons 13-23) were identified in five index cases, accounting<br />
for 20 % <strong>of</strong> negative mutation patients after DNA sequencing .<br />
Among the remaining negative index cases, a family history compatible<br />
with dominant X-linked inheritance was found in one case only . Using<br />
DNA sequencing, QMPSF and relative quantitative real-time PCR<br />
analyses, the OFD1 alteration detection level remains incomplete .<br />
However, it is likely that sporadic patients without OFD1 alterations